Literature DB >> 677236

Metastatic choroidal melanoma.

D H Char.   

Abstract

We studied the metastatic pattern of 41 patients initially referred with a primary choroidal melanoma who later developed widespread disease. In the order of frequency, the most common sites of metastatic involvement were the liver (56%), subcutaneous tissue (36.5%), and bone (7%). Whereas the median interval between enucleation and the onset of metastatic disease was approximately four years, in rare cases, metastases were diagnosed concurrently with a primary choroidal melanoma. Since patients with choroidal melanomas usually survive less than one year after the development of widespread disease, a metastatic examination should be done in all patients with pigmented choroidal tumors both before and after ocular therapy. From the data obtained in this and other studies on metastatic melanoma, a reasonable basic metastatic examination for choroidal melanoma patients should include a serum lactic dehydrogenase, a serum alkaline phosphatase, a routine chest X-ray, and a general physical examination.

Entities:  

Mesh:

Year:  1978        PMID: 677236     DOI: 10.1016/0002-9394(78)90018-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

Review 1.  Immune escape mechanisms of intraocular tumors.

Authors:  Jerry Y Niederkorn
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

2.  Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.

Authors:  ShriHari S Kadkol; Amy Y Lin; Vivian Barak; Inna Kalickman; Lu Leach; Klara Valyi-Nagy; Dibyen Majumdar; Suman Setty; Andrew J Maniotis; Robert Folberg; Jacob Pe'er
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

3.  Influence of lipid diets on the number of metastases and ganglioside content of H59 variant tumors.

Authors:  J Coulombe; G Pelletier; P Tremblay; G Mercier; D Oth
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

4.  The natural history of uveal melanomas and its therapeutic consequences.

Authors:  W A Manschot
Journal:  Doc Ophthalmol       Date:  1980-12-15       Impact factor: 2.379

5.  A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.

Authors:  S R Elshaw; K Sisley; N Cross; A K Murray; S M MacNeil; M Wagner; C E Nichols; I G Rennie
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

6.  [Safety and efficacy of interferon alfa-2b in the adjuvant treatment of uveal melanoma].

Authors:  E Richtig; G Langmann; G Schlemmer; K Müllner; G Papaefthymiou; P Bergthaler; J Smolle
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

7.  Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

Authors:  M J Hendrix; E A Seftor; R E Seftor; D A Kirschmann; L M Gardner; H C Boldt; M Meyer; J Pe'er; R Folberg
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

9.  Prevention of metastasis of intraocular melanoma in mice treated with difluoromethylornithine.

Authors:  G Sanborn; J Niederkorn; J Kan-Mitchell; D Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  Rabbit model of uveal Greene melanoma: morphologic studies of metastatic lesions.

Authors:  L H Liu; C Ni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.